A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension
Clinical trial NCT04525885 · COMPLETED
Trial details
- NCT number
- NCT04525885
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-17
- Primary completion
- 2022-09-15
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.